Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Items where Year is 2003

Group by: Creators | Item Type | No Grouping
Jump to: A | B | G | N | S | U | Y
Number of items: 9.

A

Arvidsson, Per I, Ryder, Neil, Weiss, Markus, Gross, Gerhard, Kretz, Olivier, Woessner, Ralph and Seebach, Dieter (2003) Antibiotic and hemolytic activity of a beta2/beta3 peptide capable of folding into a 12/10-helical secondary structure. Chembiochem : a European journal of chemical biology, 4 (12). pp. 1345-1347. ISSN 1439-4227

B

Branford, Susan, Rudzki, Zbigniew, Walsh, Sonya, Parkinson, Ian, Grigg, Andrew, Szer, Jeff, Taylor, Kerry, Herrmann, Richard, Seymour, John F, Arthur, Chris, Joske, David, Lynch, Kevin and Hughes, Tim (2003) Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis. Blood, 102 (1). pp. 276-283. ISSN 0006-4971

G

Galanello, Renzo, Piga, Antonio, Alberti, Daniele, Rouan, Marie-Claude, Bigler, Hilde and Séchaud, Romain (2003) Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. Journal of clinical pharmacology, 43 (6). pp. 565-572. ISSN 0091-2700

Galanello, Renzo, Piga, Antonio, Alberti, Daniele Maria, Rouan, Marie-Claude, Bigler, Hilde and Sechaud, Romain (2003) Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. Journal of clinical pharmacology, 43 (6). pp. 565-572. ISSN 0091-2700

Galanello, Renzo, Piga, Antonio, Alberti, Daniele Maria, Rouan, Marie-Claude, Bigler, Hilde and Sechaud, Romain (2003) Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. Journal of clinical pharmacology, 43 (6). pp. 565-572. ISSN 0091-2700

N

Nisbet-Brown, Eric, Olivieri, Nancy F, Giardina, Patricia J, Grady, Robert W, Neufeld, Ellis J, Sechaud, Romain, Krebs-Brown, Axel, Anderson, Judith, Alberti, Daniele Maria, Sizer, Kurt and Nathan, David G (2003) Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet, 361 (9369). pp. 1597-1602. ISSN 0140-6736

S

Skerjanec, Andrej, Berenson, James, Hsu, Chyi-Hung, Major, Pierre, Miller, Wilson H, Ravera, Christina, Schran, Horst, Seaman, John and Waldmeier, Felix (2003) The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function. Journal of clinical pharmacology, 43 (2). pp. 154-162. ISSN 0091-2700

U

Ullman, Brett R, Aja, Teresa, Deckwerth, Thomas L, Diaz, Jose-Luis, Herrmann, Julia, Kalish, Vincent J, Karanewsky, Donald S, Meduna, Steven P, Nalley, Kip, Robinson, Edward D, Roggo, Silvio, Sayers, Robert O, Schmitz, Albert, Ternansky, Robert J, Tomaselli, Kevin J and Wu, Joe C (2003) Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modifications. Bioorganic & Medicinal Chemistry Letters, 13 (20). pp. 3623-3626. ISSN 0960-894X

Y

Yang, Wei, Kowal, Colleen, Sorensen, Erik and Lassota, Piotr (2003) Genetically modified cancer models: the value of luciferase-tagged tumors and in vivo luciferase-based reporter assays in oncology drug discovery. Breast Cancer Research, 5 (Suppl ). p. 13. ISSN 1465-5411

This list was generated on Sun Oct 6 06:57:02 2024 UTC.

Search